11 Lack of supply There is a shortage of both semaglutide and tirzepatide due to their unprecedented demand, with both now listed in the FDA Drug Shortages database, allowing for compounded versions to be made (although that does not make such versions FDA-approved)
Ozempic is available in four different pre-filled, multi-dose syringe pen doses, including 0.25 mg (starting dose), 0.5 mg, 1.0 mg, and 2 mg (maximum dose)
Trichoscopy, comprehensive blood work, and a detailed clinical history can distinguish between pure TE, chronic TE, underlying FPHL, or a combination and each requires a different management plan
Nat Rev Mater 2022;7:31431
From verified research peptide suppliers like Peptira Peps that explicitly restrict sales to qualified laboratories and institutions
The medical team should explain whether a recommended treatment is established, off-label, compounded, or investigational